GlobalRPh Renal Dosing Masterv7.4
Renal Dosing Master: fast drug lookup
Source review / handoff

Ezetimibe - single agent

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Return to full drug recordAll source differencesRead selected sourcesHow to use this review

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Check source scope before reading a dose

Zetia - labeled renal guidance

Product / population
Ezetimibe (Zetia), oral tablets
Renal method
Clinical renal category or population named in the cited section
Source revision
DailyMed SPL version 8, effective 2025-11-25; posted Nov 26, 2025
Retrieved
2026-11-07
Local review status
Selected renal passages reviewed; independent clinician adjudication pending.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

Zetia - product and source limitations

If used with another lipid-lowering drug, verify that drug's dose and renal precautions separately.

What to reconcile: Apply only to the stated formulation, indication and renal population.

Selected renal passages reviewed; independent clinician adjudication pending.

Open this note and its source references
Official

Zetia - labeled renal guidance

Open original reference

DailyMed / product prescribing information · Ezetimibe (Zetia), oral tablets

Renal method: Clinical renal category or population named in the cited section
Source date: DailyMed SPL version 8, effective 2025-11-25; posted Nov 26, 2025
Retrieved: 2026-11-07

Qualified no-adjustment statement. Apply only to the population, product and renal range described in this source.

Selected renal passages reviewed; independent clinician adjudication pending.

Renal guidance: 8, renal impairment

No renal dose adjustment is needed for ezetimibe. If used with another lipid-lowering drug, verify that drug's dose and renal precautions separately.

RDM73-zetia-official-1 · Source locator: Renal guidance: 8, renal impairment

Source identity and provenance
Source family
product_label
Source
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=174e45e0-45bb-48b7-9e60-8f6cfc1d22bb
Retrieved
2026-11-07
Renal-function method
Clinical renal category or population named in the cited section
Source date/version
DailyMed SPL version 8, effective 2025-11-25; posted Nov 26, 2025
Hash meaning
SHA-256 of the local selected-source summary
Local summary SHA-256
01548238e98be9f01f1dfa6c12515a9b09743cf690b0f3ece0bc0b9e3e361c9d

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=ezetimibe&s1=RDM73-zetia-official&h1=da760810803329fb9d68d3695552ec233b5595fdf5924116dc26b2babf958f85

Top